what is (al) amyloidosis?
Published 2 years ago • 353 plays • Length 2:39Download video MP4
Download video MP3
Similar videos
-
2:09
leading in rare disease collaboration
-
2:06
alexion, astrazeneca rare disease: who we are
-
1:56
alexion | identity diagnosis
-
1:16
advancing innovation in genomic medicine for rare diseases
-
1:12
the power of diagnostics in rare disease research
-
1:38
overcoming the challenges: rare disease r&d
-
41:43
drug discovery, biotech, and ai with alex zhavoronkov, ceo, insilico medicine (cxotalk #327)
-
1:02
how do rnai therapeutics treat disease?
-
2:35
understanding amyloidosis - 3d animation & overview
-
2:37
leading in rare disease clinical trials
-
1:06
the power of asking questions in rare disease research
-
1:05
leading in rare neurological disease research
-
2:37
leading in rare disease clinical trials
-
12:09
sponsor perspective: alexion pharmaceuticals | rare disease day: 40 years of the orphan drug act
-
14:31
rare connections in nmosd (accessible version)
-
1:38
delivering for rare disease patients – every single day
-
1:09
accelerating rare disease research together
-
1:05
understanding the challenges: clinical trials for rare diseases
-
2:08
leading in rare disease r&d: tenacity & grit
-
0:32
alexion warned by the fda